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Abstract 
Background: Inclusion bodies (IBs) are biologically active protein aggregates forming natural nanoparticles with a 
high stability and a slow‑release behavior. Because of their nature, IBs have been explored to be used as biocatalysts, 
in tissue engineering, and also for human and animal therapies. To improve the production and biological efficiency 
of this nanomaterial, a wide range of aggregation tags have been evaluated. However, so far, the presence in the IBs of 
bacterial impurities such as lipids and other proteins coexisting with the recombinant product has been poorly stud‑
ied. These impurities could strongly limit the potential of IB applications, being necessary to control the composition 
of these bacterial nanoparticles. Thus, we have explored the use of leucine zippers as alternative tags to promote not 
only aggregation but also the generation of a new type of IB‑like protein nanoparticles with improved physicochemi‑
cal properties.
Results: Three different protein constructs, named GFP, J‑GFP‑F and J/F‑GFP were engineered. J‑GFP‑F corresponded 
to a GFP flanked by two leucine zippers (Jun and Fos); J/F‑GFP was formed coexpressing a GFP fused to Jun leucine 
zipper (J‑GFP) and a GFP fused to a Fos leucine zipper (F‑GFP); and, finally, GFP was used as a control without any tag. 
All of them were expressed in Escherichia coli and formed IBs, where the aggregation tendency was especially high for 
J/F‑GFP. Moreover, those IBs formed by J‑GFP‑F and J/F‑GFP constructs were smaller, rougher, and more amorphous 
than GFP ones, increasing surface/mass ratio and, therefore, surface for protein release. Although the lipid and carbo‑
hydrate content were not reduced with the addition of leucine zippers, interesting differences were observed in the 
protein specific activity and conformation with the addition of Jun and Fos. Moreover, J‑GFP‑F and J/F‑GFP nanoparti‑
cles were purer than GFP IBs in terms of protein content.
Conclusions: This study proved that the use of leucine zippers strategy allows the formation of IBs with an increased 
aggregation ratio and protein purity, as we observed with the J/F‑GFP approach, and the formation of IBs with a 
higher specific activity, in the case of J‑GFP‑F IBs. Thus, overall, the use of leucine zippers seems to be a good system 
for the production of IBs with more promising characteristics useful for pharma or biotech applications.
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Background
Inclusion bodies (IBs) are protein nanoparticles rang-
ing from 50 to 800  nm formed during the production 
of recombinant proteins and often localized in the cyto-
plasmic space of bacterial cells [1], although their forma-
tion in the periplasm has also been described [2]. In the 
past, IBs have been regarded as an undesired byproduct 
of recombinant protein production processes [3]. How-
ever, over the last 15  years it has been broadly proven 
that proteins forming IBs are biologically active [4–7]. 
The presence of native proteins forming such aggregates 
has prompted to assess their potential as biomaterials for 
a wide range of applications, including biocatalysis, tis-
sue engineering, and antimicrobial and cancer therapies 
[7–10]. They offer important advantages over their solu-
ble counterparts such as high stability [11], slow-release 
behavior [12, 13], and production through cost-effective 
processes [14]. Aiming to improve the production and 
biological efficiency of this nanomaterial, the increase of 
the aggregation tendency of proteins of interest is a key 
aspect and has been evaluated through the use of dif-
ferent aggregation tags, being VP1 [6], GFIL8 [15] and 
ELK16 [16] three representative examples. Besides, the 
scale-up of IB production and purification protocols have 
also been improved during the last decade [14, 17]. It has 
been described that the recombinant protein forming this 
biomaterial coexists with other proteins such as chaper-
ones, and also with lipids [18, 19]. However, the presence 
of these impurities has been poorly studied, and conse-
quently there is room to optimize IB composition. This is 
an important challenge to be solved in terms of IB appli-
cability, since for specific applications it is important to 
control the exact composition of these bacterial nanopar-
ticles. Thus, exploring ways to control the IB formation 
process emerges as a central strategy to improve IB purity 
and better control their physicochemical properties. In 
the present study, we have used an alternative approach 
for the generation of a new type of IB-like protein nano-
particles using leucine zippers (LZ) as aggregation-seed-
ing domains with the aim to drive protein aggregation 
and improve IB properties for industrial applications. 
In marked contrast to aggregation tags used till present 
to increase protein aggregation, LZ are protein–protein 
interaction domains consisting of amphipathic α helices 
that dimerize in parallel, either as homodimers or heter-
odimers, to form a coiled-coil [20–22]. LZ dimerization 
motifs have already been explored as protein–protein 
interaction drivers both in recombinant mammalian [23] 
and bacterial [24, 25] cells. Thus, LZ specific properties 
make these peptides promising players to improve, con-
trol, and stabilize IB quality, thus boosting their potential 
for pharma and biotech industrial applications. In this 
study, we have explored the aggregation profile of a GFP 
reporter protein fused to Jun and Fos LZ [23] at different 
positions. The purity and formation of GFP IBs have been 
studied to determine the possible role of LZ in obtaining 
purer and better controlled IBs.
Results
Construct design and modelling
In this study three different protein constructs, named 
GFP, J-GFP-F and J/F-GFP, have been engineered to eval-
uate the effect of Jun and Fos LZ on the protein aggrega-
tion process (Fig. 1a). J-GFP-F is a single fusion protein 
consisting on a GFP flanked by Jun and Fos at N- and 
C-terminus, respectively, whereas J/F-GFP is consti-
tuted by two proteins (a GFP with Jun LZ at N-terminus 
(J-GFP) and a GFP with Fos at N-terminus (F-GFP)), 
simultaneously coexpressed (Fig.  1). GFP protein has 
been used as a control without any LZ tag. The three-
dimensional structural arrangements of the constructs 
were built by iterative threading, taking advantage of 
the I-TASSER webserver [26]. The generated models 
were visually inspected and possible three-dimensional 
arrangements of the J/F units with respect to the GFP 
were selected as representative conformational arrange-
ments (Fig. 1b). In all constructs, the J/F subunits tended 
to assume a helical structure, as expected, but it was only 
possible to generate highly ordered starting domains 
for J/F-GFP. All models underwent 250  ns of atomis-
tic molecular dynamics simulations in full water solvent 
(Additional file  1: Figure S1) showing the J/F elongated 
domains to be structurally unstable leading to partially 
disordered arrangements similar to those initially mod-
elled for J-GFP-F. Among the generated models for 
J-GFP-F, no highly ordered structure was present, and 
the pool differed by the local arrangement of the J/F sub-
domains (as exemplified by two structures in Fig. 1b).
Protein production and aggregation
Cell growth was determined under the overexpres-
sion of the three different constructs used in this study 
(Fig. 2). Interestingly, a reduction in the bacterial growth 
was observed when J-GFP-F and J/F-GFP were pro-
duced, especially at 5  h (Fig.  2). Moreover, those pro-
teins that impaired the growth (J-GFP-F and J/F-GFP) 
were produced at lower levels than their GFP counter-
part (Table  1). Analyzing the protein yields at different 
production time points, it can be observed that there is 
a time-dependent production of both GFP and J/F-GFP, 
while for J-GFP-F production values kept similar at dif-
ferent times post-induction (Table 1).
Despite of the reduction in protein levels and in cell 
viability for those proteins carrying Jun and Fos (Fig.  2 
and Table  1), all constructs aggregated (Fig.  3). Spe-
cifically, the analysis of the aggregation ratio showed 
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differences among the constructs used, being the aggre-
gation ratio higher for J/F-GFP than for GFP and J-GFP-F 
(Fig. 3 and Additional file 1: Table S1).
Characteristics of purified IBs
Aiming to explore the specific nanoarchitectural char-
acteristics of the protein nanoparticles formed using the 
three different tag combinations, IBs of each construct 
were purified. In all samples, qualitative and quantita-
tive approaches with high resolution electron microscopy 
Fig. 1 Recombinant construct. a Diagram of the protein‑based constructs and their possible aggregation process as IBs depending on the 
presence or not of LZ. b Representative three‑dimensional models of the J‑GFP‑F (two models: a and b) and J/F‑GFP constructs (one model each), 
as generated by iterative threading. Construct domains are color coded as follow: GFP (green), Jun (blue), Fos (red)
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imaging of the ultrastructural morphometric of IBs 
showed a high number of well-formed nanoparticles 
with round shape and nanoscale size in the three con-
structs (Fig. 4). However, slight and important shape and 
size differences between GFP IBs and those nanopar-
ticles formed with Jun or Fos LZ were detected. First of 
all, control GFP IBs showed a very homogeneous round 
shape and smooth surface, suggesting a highly compact 
structure (Fig. 4). In contrast, Jun-Fos based IBs showed 
a high variability in shape, significantly more amor-
phous than GFP ones and with a high percentage of IBs 
showing rough and porous surface. About the size, GFP 
nanoparticles showed the highest size with a diameter of 
400–500 nm and a large mean area (Fig. 4), whereas Jun-
GFP-Fos and Jun-GFP/Fos-GFP IBs were significantly 
smaller with a lower area and a diameter around 250 nm 
in both cases (Fig. 4).
The analysis of the protein quality in terms of protein 
activity of GFP, J-GFP-F, and J/F-GFP IBs indicated that 
the addition of Jun and Fos improved the functional 
protein content when flanking the GFP, whereas no dif-
ferences were observed for J/F-GFP compared to GFP 
(Fig.  5a). This indicates that the GFP forming J-GFP-F 
nanoparticles has better quality and, in consequence, 
higher fluorescence per μg of protein than the two other 
constructs used. Interestingly, the comparison of the spe-
cific fluorescence of GFP forming the IBs with the soluble 
version of this protein indicated that although the activ-
ity of the soluble form of all the proteins was higher than 
when forming IBs, the difference between soluble and 
IB-forming proteins was especially greater in the case of 
GFP (Fig. 5b).
The conformational properties of the proteins embed-
ded in the IBs were investigated by Fourier transform 
infrared (FTIR) spectroscopy [27]. The spectra were 
collected before and after hydrogen/deuterium (H/D) 
exchange to allow a better assignment of the Amide I 
band components to the protein secondary structures 
[28, 29]. GFP and J/F-GFP IBs displayed comparable IR 
response, while J-GFP-F IBs showed distinct peak posi-
tions and relative intensities of the spectral components 
assigned to β-sheets (Fig. 6 and Additional file 1: Figure 
S3). In particular, the absorption spectra (both before and 
after H/D exchange) of J-GFP-F IBs were more similar to 
those of the soluble GFP (Additional file 1: Figure S3) and 
the main β-sheet peak showed a higher downshift after 
H/D exchange compared to GFP and J/F-GFP IBs (Fig. 6). 
In the deuterated J-GFP-F, this component occurred at 
around 1620 cm−1, a peak position near to that observed 
for the main β-sheet band of soluble GFP, which indeed 
was observed around 1622 cm−1 (Fig. 6) [30, 31]. Overall, 
these data suggested that the Jun and Fos motifs modu-
lated the conformational features of the formed IBs.
Purity of IBs
Interestingly, J-GFP-F and J/F-GFP nanoparticles have 
a degree of protein purity more than twice than that 
observed for parental GFP nanoparticles (Fig. 7). Besides, 
the analysis of lipid and carbohydrate content in IBs 
indicated that the presence of Jun and Fos in J-GFP-F 
increased the presence of these co-contaminants while 
the strategy for the production of IBs using J/F-GFP 
showed no significant differences with GFP in lipid and 
carbohydrate content (Fig. 8).
Discussion
IBs are protein aggregates ranging at nanoscale that have 
been widely studied from different perspectives. Since 
most of the recombinant proteins form IBs when over-
expressed in bacteria [3], and some of them are only pro-
duced in this insoluble format, these nanoparticles have 
been broadly used as a source to obtain the soluble form 
of a wide range of protein of interest [32]. On the other 
hand, by being protein nanoparticles rich in functional 
recombinant protein, IBs have also been explored as a 
new class of biomaterial with promising applications in 
biocatalysis, tissue engineering, and human and animal 
therapies [7–9, 11]. However, although different aggre-
gation tags have been used to promote their formation, 
the impact of these aggregation domains in the quality 
of protein aggregates has not been addressed so far. For 
that, in this work, we have explored if the use of Jun and 
Fig. 2 Optical density values of recombinant bacteria cultures in LB 
medium after protein expression induction. Circles represent E. coli 
pET22b/GFP (GFP), triangles E. coli pET22b/Jun‑GFP‑Fos (J‑GFP‑F), 
and squares represent E. coli pETDuet‑1‑Jun‑GFP/Fos‑GFP (J/F‑GFP). 
Different letters depict significant differences between the growth 
curves (p ≤ 0.0001)
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Fos LZ dimerization motifs could drive the formation 
of IBs in a more controlled way in terms of quality. The 
results obtained proved that the constructs containing 
Jun and Fos (Fig. 1a), although they showed some toxic-
ity to the producer cells (Fig. 2), they were produced as 
IBs with aggregation ratios higher than GFP (Fig.  3), 
proving that the aggregation propensity can be improved 
by using this strategy. The enhancement of the aggrega-
tion propensity can be attributed to the formation of Jun 
and Fos interactions among constructs, confirming that 
while the Jun and Fos domains seem to explore a number 
of partially disordered conformations when free in solu-
tion, this does not hinder the formation of stable aggre-
gates. Interestingly, the aggregation ratio was observed 
to be higher for J/F-GFP than for J-GFP-F (Fig.  3). This 
can be rationalized in terms of competition between 
intramolecular and intermolecular Jun/Fos interactions. 
In J-GFP-F the Jun and Fos domains are entangled due 
to intramolecular interactions between them (Additional 
file 1: Figure S1). Their association within the same con-
struct competes with the formation of dimers, or multim-
ers, where Jun and Fos fragments belonging to different 
molecules interact and bond with each other. In both 
cases the two interacting fragments are the same, thus 
their energetic is expected to be close. At room tempera-
ture we might expect the competition and coexistence of 
monomers, dimers, and multimers in solution. However, 
it is also worth noting that in J-GFP-F, each Jun unit will 
be close to a Fos domain; this corresponds to a high local 
concentration of the partner, thus favoring the intramo-
lecular entangled J-GFP-F. On the other hand, when the 
Jun/Fos domains are uncoupled, independently bound 
to different GFPs (as in J/F-GFP), there is obviously no 
competition between intermolecular and intramolecular 
interactions.
The study of the specific physicochemical character-
istics of purified GFP, J-GFP-F and J/F-GFP IBs showed 
that, depending on the LZ strategy used, it’s possible to 
modulate IBs features such as specific activity, size, pro-
tein purity and presence of contaminants such as lipids 
and carbohydrates. The presence of LZ has a significant 
impact on both the size and shape of  the aggregates, 
with IB diameters around 250 nm and more amorphous 
forms, while GFP IBs have a size of 400–500  nm and a 
higher average surface and higher roughness (Fig.  4). 
However, despite the differences in size, which can be 
correlated with the lower production yields achieved 
for those constructs containing LZ (Table  1), surface 
rugosity and roundness, ultrastructural morphometry 
of J-GFP-F and J-/F-GFP IBs (Fig.  4) agree with other 
conventional IBs produced in E. coli [33] and other cell 
factories such as Lactococcus lactis [34] or Pichia pasto-
ris [35]. Interestingly, more amorphous shape and rough 
surface of J-GFP-F and J/F-GFP IBs could be indicative 
of significant differences in protein production and nano-
particle formation. In fact, the nanoarchitectural aspect 
of GFP IBs shows nanostructures with higher size, com-
pactness and smooth surface than Jun and Fos IBs, which 
appear as more soft particles with a rough surface, more 
amorphous shape, and lower mean size. These nanoscale 
differences can play a great role in differential function-
alities of proteins forming IBs in potential therapeuti-
cal applications. Then, low size, amorphous shape, and 
rough surfaces increase surface/mass  ratio and, there-
fore, potential protein release at in  vitro and in  vivo 
conditions, becoming suitable and desired morphomet-
ric characteristics for more efficiently releasing nano or 
micro-platforms of drug delivery systems. Moreover, 
although smaller, GFP proteins forming J-GFP-F nano-
particles had a specific activity significantly higher than 
the other constructs that we tested (Fig. 5a), which is in 
accordance with FTIR spectra (Fig.  6 and  Additional 
file  1: Figure S3). In particular, after H/D exchange, the 
main β-sheet peak of J-GFP-F IBs was observed to be 
very close to that observed for the soluble GFP, indicating 
the maintenance of native-like conformational features. 
Although J/F-GFP IBs showed no differences in the qual-
ity of the protein forming the IBs when compared to GFP 
(Fig. 5a), both J-GFP-F and J/F-GFP proteins forming IBs 
presented activities closer to the soluble form than GFP 
produced without tags (Fig.  5b). This indicates that the 
presence of Jun and Fos had a positive impact on the IB 
protein quality. This result agrees with previous studies 
that have described that the recombinant protein pro-
duced or the strain used can have an impact on the con-
formational quality of the proteins forming IBs [36–38].
On the other hand, the analysis of the elements form-
ing such aggregates showed that J-GFP-F and J/F-GFP 
IBs had less protein impurities (Fig.  7), which suggests 
that Jun and Fos sequences drive a more controlled for-
mation of the protein nanoparticles in terms of protein 
composition. By contrast, the presence of lipids and car-
bohydrates could not be decreased by the addition of LZ 
(Fig. 8). The amount of both lipids and carbohydrates in 
J/F-GFP IBs was comparable to the levels in GFP IBs, 
whereas in the case of J-GFP-F was even higher (Fig. 8). 
This could be correlated with the LZ interactions in each 
construct. As previously discussed, in J-GFP-F the Jun 
and Fos domains of different molecules compete with 
intramolecular interactions between the two domains, 
and this could drive the formation of less compact aggre-
gates which could contain more lipids and carbohydrates.
Overall, these results demonstrate that aggregation-
seeding domains based on LZ peptide–peptide inter-
action can drive the formation of a specific type of IBs, 
improving their quality in terms of protein content 
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(Fig.  7), and in one of the approaches increasing spe-
cific activity (Figs.  5a and 6). However, those IBs with 
higher specific activity (J-GFP-F) are produced through 
a strategy that has a negative impact in the presence of 
contaminants such as lipids and carbohydrates (Fig.  8). 
On the contrary, the strategy based on the coexpression 
of Jun-GFP and Fos-GFP (J/F-GFP) to form IBs, even 
though it did not display any increase in the protein qual-
ity (Fig.  5a), had no negative impact in the content of 
lipids and carbohydrates (Fig. 8), therefore showing that 
it could be a promising approach for the production of 
IBs with higher recombinant protein content and less 
protein impurities.
Conclusions
Altogether this study proved that the use of Jun and Fos 
LZ is a good strategy for the production of IBs with more 
appealing characteristics that might be useful for pharma 
or biotech applications. This is especially relevant for J/F-
GFP approach, which allowed producing hybrid IBs with 
increased aggregation ratio and protein purity without 




The sequence encoding amino acid residues 2–238 of 
the enhanced GFP (EGFP) was fused downstream of 
sequence encoding Fos 118–210 (bFos) or Jun 257–318 
(bJun) using the linker sequence encoding SGGGSGGS 
to construct Fos-GFP and Jun-GFP, respectively. For 
the Jun-GFP-Fos construct, the sequence encoding Jun 
257–318 (bJun) was fused at the N-terminus, while the 
sequence encoding Fos 118–210 (bFos) was fused at 
the C-terminus, using in both cases the linker sequence 
encoding SGGGSGGS. The Jun-GFP-Fos construct was 
cloned into pET22b  (AmpR) vector (pET22b-Jun-GFP-
Fos), while Jun-GFP and Fos-GFP constructs were cloned 
in pETDuet-1  (AmpR) to co-express them (pETDuet-
1-Jun-GFP/Fos-GFP). As a control, residues 2–238 of 
EGFP were cloned into pET22b. The DNA sequences 
corresponding to each gene sequence were codon opti-
mized for its expression in Escherichia coli (GeneArt, 
Germany).
Preparation of E. coli competent cells
Escherichia coli BL21 (DE3) cultures were grown over-
night (ON) in LB medium at 37  °C with shaking at 
250 rpm. A 1/100 inoculum was done in 50 ml of LB and 
the culture was grown until the optical density  (OD600nm) 
reached a value between 0.2 and 0.4. After that, cultures 
were centrifuged (4000×g) at 4  °C for 15  min. Pellets 
were resuspended in 12.5 ml of cold and sterile 50 mM 
 CaCl2 and incubated for 45 min in an ice bath. Cells were 
centrifuged again as described above and resuspended in 
1.25 ml of cold and sterile 50 mM  CaCl2 in glycerol (15% 
v/v) to prepare aliquots of 200  µl, which were stored at 
− 80  °C. To transform the cells, 40  ng of plasmid DNA 
were added to 200  µl of competent cells. The mixtures 
were incubated on ice for 30–60  min, warmed up to 
42 °C for 45 s and placed on ice for 30 s. After incubation, 
800  µl of LB media were added, and transformed cells 
were incubated at 37  °C for 1  h. Finally, the cells were 
plated on LB-agar plates containing the corresponding 
antibiotic.
Protein production
Escherichia coli BL21 (DE3)/pET22b-GFP, E. coli 
BL21(DE3)/pET22b-Jun-GFP-Fos (J-GFP-F) and E. coli 
BL21(DE3)/pETDuet-1-Jun-GFP/Fos-GFP (J/F-GFP) 
ON cultures were inoculated in 50  ml of LB media 
with 100  µg/ml ampicillin in 200-ml flasks at an initial 
 OD600nm = 0.05. Each culture was grown at 37  °C and 
250 rpm until the  OD600nm was 0.5 and 1 mM isopropyl-
β-d-thiogalactoside (IPTG) was added to induce recom-
binant protein expression. At times 0, 1, 3, and 5 h after 
IPTG induction, 1 ml samples were collected for protein 
fractioning. These cultures were performed by triplicate.
Protein fractionation
Samples of 1  ml were harvested by centrifugation at 
6000×g at 4 °C for 15 min and the pellet was resuspended 
in 0.5 ml phosphate buffered saline (PBS) supplemented 
with protease inhibitor (Complete EDTA-free, Roche, 
Switzerland) to prevent protein proteolysis. Then, ice-
jacketed samples were disrupted by sonication (2 cycles 
of 1.5 min at 10% amplitude under 0.5 s cycles) (Branson 
Ultrasonic SA, Switzerland). These samples were centri-
fuged at 15,000×g and 4 °C for 15 min to separate soluble 
Fig. 3 Protein aggregation ratio (%) for each construct over time. 
Black, dark grey, and light grey bars represent GFP, J‑GFP‑F, and 
J/F‑GFP, respectively. Significant differences for construct (p ≤ 0.05) 
and for time (p ≤ 0.1; Additional file 1: Table S1)
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and insoluble fractions protein fractions. Samples were 
stored at − 80 °C.
Protein determination
Soluble and insoluble protein fractions were analyzed 
by denaturing SDS-PAGE (15% acrylamide). Denaturing 
buffer (Laemli 4×: Tris base 1.28  g, glycerol 8  ml, SDS 
1.6 g, β-mercaptoethanol 4 ml, urea 9.6 g in 20 ml) was 
added to the insoluble and soluble fractions to a final 
concentration of 1× (see protein fractioning). Soluble 
and insoluble protein fractions were boiled for 10 and 
45  min, respectively. At that time, samples were loaded 
onto the gel. SDS-PAGE protein bands were transferred 
onto PVDF membranes and identified using a com-
mercial anti-GFP antibody (1:1000, sc-9996, Santa Cruz 
Biotechnology, USA), followed by an incubation with a 
secondary ALP-conjugated anti-mouse IgG (whole mol-
ecule) antibody (1:20,000, A4313, Sigma-Aldrich, USA). 
The amounts of recombinant protein were estimated by 
comparison with known amounts (usually ranging from 
125 to 1000 ng) of T22-GFP protein [36]. Protein bands 
were visualized with a solution of NBT/BCIP (B6404, 
Fig. 4 Representative FESEM images of the isolated IBs for each construct: GFP IBs, J‑GFP‑F IBs and J/F‑GFP IBs. Bars size: 200 nm. IB mean area 
 (nm2), mean diameter (nm) and roundness (%) was calculated for each construct IB (****p ≤ 0.0001)
Page 9 of 13Roca‑Pinilla et al. Microb Cell Fact          (2020) 19:175  
Sigma-Aldrich, USA), and images were obtained using a 
Color Image Scanner. ImageJ software was used to per-
form densitometric analyses of the bands.
Determination of specific fluorescence
Fluorescence intensity of the three constructs in 1  ml 
samples was determined in a Varian Cary Eclipse fluores-
cence spectrometer (Agilent Technologies, Australia) at 
excitation and emission wavelengths of 480 and 510 nm, 
respectively. Since protein amounts in 1  ml samples for 
each construct, fraction and time are known (see protein 
determination), specific fluorescence was calculated by 
dividing the fluorescence intensity by the amount of pro-
tein for each construct, time and fraction.
Protein purity assessment
After separation, the gels were carefully transferred to a 
plastic tray filled with 200 ml of distilled water and agi-
tated at 50 rpm to remove SDS traces. The staining solu-
tion (Coomassie Brilliant BlueR-250 Staining Solution, 
Fig. 5 Specific fluorescence of the protein constructs. IB specific fluorescence for the three constructs (a). Specific fluorescence ratio of the 
insoluble fraction compared to the soluble fraction specific fluorescence (b). Black, dark grey, and light grey bars represent GFP, J‑GFP‑F, and J/F‑GFP, 
respectively. * shows statistically significant differences compared to the GFP construct (p ≤ 0.05), and different letters also show statistically 
significant differences (p ≤ 0.05)
Fig. 6 Second derivatives of the FTIR absorption spectra of GFP, 
J‑GFP‑F and J/F‑GFP IBs and of soluble GFP. Samples were measured 
in form of protein films, obtained by solvent evaporation, and after 
re‑hydration by  D2O in order to allow H/D exchange. Selected peaks 
and the typical spectral region of the different protein secondary 
structures after H/D exchange are indicated. α, α‑helices; β, β‑sheets; 
βt, β‑turns; RC, random coils
Fig. 7 Protein purity of IBs. For each construct, protein purity was 
determined by densiometric image‑analysis, comparing the amount 
of the specific recombinant construct to the whole protein amount 
of the IB. Different letters depict statistically significant differences 
(p ≤0.05)
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Bio-Rad, USA) was added into the gels (and incubated for 
1 h at room temperature (RT) and revealed with destain-
ing solution (50%  H2O, 40% methanol, 10% acetic acid 
(v/v)) until bands were clearly visible. The gel images 
were acquired by a Color Image Scanner and analyzed 
with the ImageJ software.
Protein aggregation ratio
The amount of recombinant protein of the soluble and 
insoluble fraction for each construct was determined as 
explained above. After that, the aggregation ratio was cal-
culated by dividing the quantity of the insoluble fraction 
for each time, replicate and construct by the quantity of 
protein in the respective soluble fraction.
Purification of protein nanoparticles
Bacterial cultures were processed 3  h post-induction 
through a combination of mechanical and enzymatic 
disruption methods. Protease inhibitors (Complete 
EDTA-free, Roche, Switzerland), phenylmethanesulpho-
nylfluoride (PMSF) and lysozyme were added to the cul-
ture at a final concentration of 0.4 mM (Sigma-Aldrich, 
USA) and 1  µg/ml (Sigma-Aldrich, USA), respectively. 
After 2 h of incubation at 37 °C and 250 rpm the culture 
was centrifuged at 6000×g and resuspended in 30 ml of 
PBS supplemented with protease inhibitors (Complete 
EDTA-free, Roche, Switzerland). Then, the mixture was 
ice-jacketed and sonicated for 4 cycles of 1.5  min at 
10% amplitude under 0.5  s cycles (Branson Ultrasonic 
SA, Switzerland). After sonication, the mixture was fro-
zen ON at − 80 °C. The mixture was thawed and Triton 
X-100 was added (0.4% (v/v)) and incubated for 1 h at RT. 
After this treatment, the mixture was frozen at − 80  °C 
for 2 h and then thawed for several cycles until no viable 
bacterial growth was detected. After that, 125 µl of Noni-
det P40 (NP-40) was added and incubated for 1 h at 4 °C. 
Then, DNA was removed with DNAse at a final concen-
tration of 0.6 µg/ml and 0.6 mM  MgSO4 for 1 h at 37 °C. 
Samples were centrifuged at 15,000×g for 15 min at 4 °C. 
Pellets containing IBs were washed with 25 ml lysis buffer 
(50 mM Tris–HCl pH 8, 100 mM NaCl, 1 mM EDTA and 
Triton X-100 0.5% (v/v)). Finally, pellets were centrifuged 
at 4  °C for 15  min and 15,000×g and stored at − 80  °C 
until analysis. The IBs were quantified by western blot 
using a monoclonal anti-GFP antibody (1:1000, sc-9996; 
Santa Cruz Biotechnology, USA). All incubations were 
done under agitation.
Electron microscopy
Field Emission Scanning Electron Microscope (FESEM) 
was used to visualize the ultrastructural morphology 
(size and shape) of protein nanoparticles in a nearly 
native state. For that, protein samples were directly 
deposited over silicon wafers (Ted Pella, USA), air dried, 
and observed with a high resolution standard second-
ary electron detector through a FESEM Merlin (Zeiss, 
Germany) operating at 2 kV. As a quantitative morpho-
metric measurement, the mean area of IBs for each con-
struct was analyzed as estimator of size with the Image J 
software. The number of particles was 30, 9, 11, for GFP, 
J-GFP-F and J/F-GFP, respectively. Using mean area val-
ues, the mean diameter of each particles was calculated, 
and the diameter was also used as  an estimator of size. 
The roundness of IB particles for each construct was also 
evaluated (n = 50/construct), as an assessment of particle 
shape.
Total carbohydrate and lipid analysis
The total lipid amount in IBs was determined following 
a sulfo-phospho-vanillin colorimetric assay. Briefly, 500–
1000 µl of each sample were centrifuged at 15,000×g and 
4  °C for 15  min. The supernatants were removed, and 
Fig. 8 Lipid (a) and carbohydrate (b) content of for each IB construct. Different letters indicate statistically significant differences (p ≤0.01 (a) and 
p ≤0.05, (b))
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each pellet was dried by means of a vacuum lyophilizer 
(SpeedVac™, ThermoFisher) and dissolved in 200  µl of 
chloroform in a capped glass tube. The chloroform was 
evaporated at 63  °C in a fume hood. To each tube, 2 ml 
of 18 M sulfuric acid were added. The samples were then 
incubated for 10 min in a boiling water bath. After that, 
each tube was cooled down in ice for 5 min. Five milli-
liters of phosphoric acid-vanillin reagent (100 ml of 85% 
(v/v) phosphoric acid and 0.12  g of vanillin, (Sigma-
Aldrich, Germany)) were added to the tubes and incu-
bated for 15  min at 37  °C. The tubes were cooled for 
15 min in ice and absorbance was measured at 530 nm. 
For the standard curve, a range of 10-100 μg triolein (dis-
solved in chloroform) was used. To determine the total 
content of carbohydrates present in the IBs samples, a 
phenol–sulfuric assay was performed. A glucose stand-
ard was prepared ranging  from 0 to 150 nanomols and 
150-225 µl of IBs were centrifuged at 15,000×g and 4 °C 
for 15 min. The supernatant was removed, and each pel-
let was dried with a vacuum lyophilizer. A total of 150 μl 
of 18 M sulfuric acid was added, followed immediately by 
30 μl of 5% phenol. Samples were incubated at 90 °C for 
5 min and then cooled to RT, and absorbance was meas-
ured at 490 nm. All assays were performed in triplicate.
Structure modelling
J-GFP-F and J/F-GFP were modelled by iterative thread-
ing, as implemented the I-TASSER server [26] without 
applying any additional restrains. Given the primary 
sequence of the three constructs the server allows gen-
erating possible three-dimensional models by mul-
tiple threading alignment. The quality of the models 
was assessed both by their C-score, which was nega-
tive in all cases, and visually. For J-GFP-F, both the first 
(C-score = − 1.86) and the second (C-score = − 2.36) 
modes were chosen as these models showed different 
arrangements of the Jun/Fos domains. For both J-GFP 
(C-score = − 1.68) and F-GFP (C-score = − 2.87) the first 
model was chosen.
Molecular dynamics protocol
For all the systems, the free construct was minimized, 
placed in a cubic box with a water layer of 0.7  nm and 
 Na+  Cl- ions to neutralize the system, and a second 
minimization was performed. We used AMBER99SB-
ILDN [37] force field and Simple Point Charge water. 
NVT and NPT equilibrations were run for 100  ps, fol-
lowed by 250  ns NPT production run at 300  °K. The 
temperature was controlled with a modified Berend-
sen thermostat  [38], the pressure with an isotropic Par-
rinello-Rahman at 1 bar. The iteration time step was set 
to 2  fs with the Verlet integrator and LINCS [39]  con-
straint. Periodic boundary conditions were used. All 
simulations and their analysis were run as implemented 
in the GROMACS package [40].
FTIR analysis
IB samples were resuspended in a few hundred micro-
liters of 20  mM of sodium phosphate buffer pH 7.4 
and 2–3  µl of the suspension at 1  μg/μl were deposited 
in several drops on a  BaF2 window and dried at RT in 
order to obtain a protein film. In particular, different 
sample concentrations were analyzed in order to obtain 
thin (to avoid excessive absorption) and uniform films 
without cracks [28]. Soluble GFP at 2 mg/ml in 20 mM 
sodium phosphate buffer pH 7.4, was analyzed in the 
form of a protein film as for IB samples. The transmis-
sion FTIR absorption spectra were then acquired by 
the Varian 670-IR FTIR spectrometer coupled to the 
Varian 610-IR infrared microscope (both from Varian, 
Australia) equipped with a mercury cadmium telluride 
nitrogen-cooled detector. The following conditions were 
employed: 2 cm−1 spectral resolution, 25 kHz scan speed, 
512 scan co-additions, and triangular apodization. Sev-
eral areas for each sample were measured to verify the 
reproducibility of the spectral results. Only absorption 
spectra with the Amide I band intensity below 0.8 were 
considered reliable. For H/D exchange, the protein film 
on the  BaF2 window was rehydrated by the deposition of 
8 μl of  D2O around the dried film. The chamber was then 
tightly closed by a second window using a flat O-ring and 
incubated for 5 h at RT to allow H/D exchange [28, 34]. 
The FTIR spectra of the  D2O-rehydrated samples were 
collected as described above.
Protein spectra were obtained after subtraction of the 
proper reference spectra strictly collected under the same 
conditions. The second derivatives [41] were calculated 
after spectral smoothing by the Savitsky-Golay method. 
Data collection and analysis were performed using the 
Resolutions-Pro software (Varian, Australia).
Statistical analysis
All quantitative data are presented as mean val-
ues ± standard error of the mean (x̅ ± SEM). Normality 
of the data was determined by a Shapiro–Wilk test. For 
IB roundness, the data were normalized with the follow-
ing formula: sqrt(max(x + 1) - x), where x is IB round-
ness and max the maximal roundness value in the data. 
A one-way ANOVA was conducted for all quantitative 
results except for IB surface and specific fluorescence 
measures. For the latter, values were compared with an 
independent sample t-test. Finally, we did Post hoc com-
parisons using the Tukey HSD test for all data analyzed 
by the ANOVA method. The level of significance was set 
at p < 0.05. Measures were done in triplicate, except for IB 
mean area, diameter and roundness, as indicated above. 
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All statistical analyses were performed using the RStudio 
Statistical Software (RStudio, Inc., USA).
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Additional file 1. Figure S1. Overlap between starting model (lighter 
shades) and final configuration (darker shades) of the J‑GFP‑F (two 
models: a and b) and J/F‑GFP constructs (one model each), after 250 ns of 
molecular dynamics simulation. The generated models were minimized, 
placed in a cubic water box, minimized again, equilibrated and, for each 
construct, 250 ns of molecular dynamics simulation were performed. 
Large rearragements of the Jun/Fos domains were observed. Construct 
domains are color coded as follow: GFP (green), Jun (blue), Fos (red). Fig-
ure S2. (a) Representative FESEM images of the isolated IBs for each con‑
struct: GFP IBs, J‑GFP‑F IBs and J/F‑GFP IBs. Bars size represent 200 nm. (b) 
Frequency distribution of IBs ultrastructural morphometry quantification 
for each construct: size (area  (nm2) and diameter (nm)) and shape (round‑
ness (%)). Figure S3. A) FTIR absorption spectra of the protein films. B) FTIR 
absorption spectra collected after re‑hydration of the protein films with 
 D2O for 5 h. GFP and J/F‑GFP IBs displayed similar absorption spectra both 
as film and after re‑hydration, while J‑GFP‑F IBs showed distinct spectral 
features. As a control, the absorption spectra of the soluble GFP are also 
shown. Supplementary Table 1. Statistics for the protein aggregation 
ratio (%) for each construct over time. (a) Aggregation ratio (%) differences 
between the three constructs and (b) aggregation ratio (%) differences 
for each construct over time. Different letters mean statistically significant 
difference (Post‑hoc Tukey HSD (THSD) comparisons).
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